Form D Explorer

Form D — Thiogenesis Therapeutics, Corp.

0001062993-25-013902 · filed 2025-08-08

Offering

Industry: Other
Exemptions: 06b
Total offering: $125,450
Total sold: $125,450
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Thiogenesis Therapeutics, Corp.
CIK: 1877778
Entity: Corporation
Jurisdiction: ONTARIO, CANADA
Year incorporated: —
Address: 4 KING STREET WEST, SUITE 401
TORONTO, A6 M5H 1B6
Phone: (888) 223-9165

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Brook G. Riggins · Executive Officer

Toronto, A6 Find on LinkedIn ↗
Patrice Rioux · Executive Officer

Toronto, A6 Find on LinkedIn ↗
W. Hogan Mullally · Director

Torontoonta, A6 Find on LinkedIn ↗
Kim Tsuchimoto · Director

Toronto, A6 Find on LinkedIn ↗
Christopher Starr · Director

Toronto, A6 Find on LinkedIn ↗

View original on SEC EDGAR.